| Home page | Contact us | Selected articles | A-Z Index of topics | Newsgroup |
| Subscribe | Order back issues | Article extracts | Back issue contents | Autism books |
From Volume 3 Number 12
WESTMEAD, Australia: The
intestinal hormone secretin, considered by some to be a promising drug in the
treatment of autism, does not improve the symptoms and should not be used to
treat the disorder, according to a new review of studies.
After analysing data from 14
high-quality studies involving 618 patients with autistic spectrum
disorders, Dr Katrina Williams of the Children's Hospital at Westmead,
Australia, and colleagues found no evidence that doses of intravenous
secretin improve the social, behavioural or communication problems associated with autism …
To read the entire article you need to order this back issue
| Search this site
|
|
| BACK ISSUE CONTENTS AND FRONT COVERS | ||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| VOLUME 1, Number: | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | VOLUME 2, Number: | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | |
| VOLUME 3, Number: | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | VOLUME 4, Number: | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | ||||
| Home page | Contact us | Selected articles | A-Z Index of topics | Newsgroup |
| Subscribe | Order back issues | Article extracts | Back issue contents | Autism books |
